Special Issue "Advances in Pancreatic Cancer Research"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 May 2019
Pancreatic ductal adenocarcinoma (PDAC) represents one of the most challenging human cancers to be treated, with projections foreseeing it becoming the second leading cause of cancer death by 2030 in both Europe and the United States. Furthermore, neuroendocrine pancreatic tumors (pNETs) are heterogeneous malignancies, and their incidence has steadily increased in the last three decades. Although many studies have been carried out on these malignancies, the currently available treatments do not obtain suitable results. Hence, novel research strategies are needed to better define diagnostic and therapeutic algorithms for the next decade.
The focus of this Special Issue is to consider the following research aspects of both PDAC and pNET: a) primary and secondary prevention; b) biology and genomic characterization； c) innovations in multidisciplinary management including diagnosis, surgery, radiotherapy, and chemotherapy in the adjuvant, neoadjuvant and metastatic settings; d) molecularly-targeted drugs and immunotherapy.
Dr. Nicola Silvestris
Dr. Oronzo Brunetti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pancreatic ductal adenocarcinoma
- pancreatic neuroendocrine tumor
- biology and genomic characterization
- targeted drugs
- translational research